BridgeMD
Compares treatment options for Supraventricular Tachycardia (SVT)
Official title Adenosine vs Diltiazem for Treatment of SVT in the ED
ClinicalTrials.gov ID: NCT06993038
What this study is testing
What is adenosine?
adenosine is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for supraventricular tachycardia (svt).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a small, pilot study with a primary goal of assessing patient perceptions of two medication treatments for supraventricular tachycardia in adult patients treated in the Emergency Department.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- Adult patients (18 years and older)
- Diagnosis of acute, stable SVT in the emergency department
You likely can't join if
- Receipt of IV AV-nodal blocking agents prior to study enrollment (includes adenosine, non-dihydropyridine calcium channel blockers, beta-antagonists...
- Reported or confirmed personal history of Wolff-Parkinson-White (WPW) syndrome
- History of heart failure with reduce ejection fraction (HFrEF) (LVEF\</= 40%)
- Severe bronchoconstrictive lung disease
- Prior hypersensitivity to study medication
- Previously enrolled in pilot study
See the full eligibility criteria
- Adult patients (18 years and older)
- Diagnosis of acute, stable SVT in the emergency department
- Receipt of IV AV-nodal blocking agents prior to study enrollment (includes adenosine, non-dihydropyridine calcium channel blockers, beta-antagonists in pre-hospital and/or hospital setting).
- Reported or confirmed personal history of Wolff-Parkinson-White (WPW) syndrome
- History of heart failure with reduce ejection fraction (HFrEF) (LVEF\</= 40%)
- Severe bronchoconstrictive lung disease
- Prior hypersensitivity to study medication
- Previously enrolled in pilot study
- Pregnant
- Incarcerated
The study team makes the final eligibility decision.
Where it's taking place
- Iowa City, Iowa, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Iowa City, Iowa, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.